Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: Reinfection and clinical outcome [2]

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 1, 2005, Pages 76-77

  Cameron, E A B ^a   Bell, G D ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DUODENUM ULCER; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; LETTER; LONG TERM CARE; PRIORITY JOURNAL; REINFECTION; VIET NAM;

BIOPSY; BREATH TESTS; DUODENAL ULCER; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 21744436259     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02521.x     Document Type: Letter

References (5)

1. Wheeldon T-U, Hoang TTH, Phung DC, Bjorkman A, Granstrom M, Sorberg M. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Aliment Pharmacol Ther 2005; 21: 1047-53.
2. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 2002; 16: 167-80.
3. van der Ende A, van der Hulst RWM, Dankert J, Tytgat GNJ. Reinfection versus recrudescence in Helicobacter pylori infection. Aliment Pharmacol Ther 1997; 11 (Suppl. 1): 55-61.
4. Bell GD, Powell KU, Burridge SM, et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med 1993; 86: 375-82.
5. Gisbert JP, Khorrami S, Calvet X, Gabriel R, Carballo F, Pajares JM. Meta-analysis: Proton pump inhibitors vs. H2-receptor antagonists - their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther 2003; 18: 757-66.